Apigenin and Carbenoxolone Co-Treatment Induces Potent Cytotoxicity in CAL-27 Oral Squamous Cell Carcinoma: A Morphological and Dose-Response Study
Allied Medical Research Journal · 30.04.2026 · 40
DOI: 10.59564/amrj/04.02/006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allied Medical Research Journal, online erschienen am 30.04.2026. Verfasst von Amna Bibi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma is a major health burden across the globe due to its widespread incidence, limited effective therapeutics, and high recurrence rates. Natural and synthetic compounds such as Apigenin (API) and Carbenoxolone (CBX) have shown significant antitumor potential against various cancer types. The current study aimed to evaluate the anti-proliferative potential of API and CBX, alone or in combination in the CAL-27 oral cancer cell line.
Methods
MTT assay was used to analyze the cytotoxic potential of API, CBX, and their combination in the CAL-27 cell line. Differential Interference Contrast (DIC) microscopy was performed to identify alterations in cellular morphology after treatment.
Results
The half maximal inhibitory concentrations for API and CBX were calculated as 50 µM and 200 µM respectively. Significantly greater inhibition of 86.37% (p-value
Zitieren
APA
Bibi, A., Imad, R., Hashmat, S., Hameed, A., & Henry, A. (2026). Apigenin and Carbenoxolone Co-Treatment Induces Potent Cytotoxicity in CAL-27 Oral Squamous Cell Carcinoma: A Morphological and Dose-Response Study. Allied Medical Research Journal, 40. https://doi.org/10.59564/amrj/04.02/006
Vancouver
Bibi A, Imad R, Hashmat S, Hameed A, Henry A. Apigenin and Carbenoxolone Co-Treatment Induces Potent Cytotoxicity in CAL-27 Oral Squamous Cell Carcinoma: A Morphological and Dose-Response Study. Allied Medical Research Journal. 2026:40. doi:10.59564/amrj/04.02/006
BibTeX
@article{Bibi2026,
author = {Bibi, Amna and Imad, Rehan and Hashmat, Shazia and Hameed, Abdul and Henry, Alfred},
title = {Apigenin and Carbenoxolone Co-Treatment Induces Potent Cytotoxicity in CAL-27 Oral Squamous Cell Carcinoma: A Morphological and Dose-Response Study},
journal = {Allied Medical Research Journal},
year = {2026},
pages = {40},
doi = {10.59564/amrj/04.02/006}
}
EUVIMED